Loomis Sayles & Co. L P Has $11.35 Million Holdings in TriMas Corporation $TRS

Loomis Sayles & Co. L P lifted its position in TriMas Corporation (NASDAQ:TRSFree Report) by 42.5% in the 2nd quarter, Holdings Channel.com reports. The institutional investor owned 396,533 shares of the industrial products company’s stock after acquiring an additional 118,313 shares during the period. Loomis Sayles & Co. L P’s holdings in TriMas were worth $11,345,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in TRS. Pzena Investment Management LLC lifted its stake in TriMas by 2.0% in the second quarter. Pzena Investment Management LLC now owns 2,177,761 shares of the industrial products company’s stock valued at $62,306,000 after acquiring an additional 42,207 shares during the last quarter. Irenic Capital Management LP bought a new stake in shares of TriMas in the 1st quarter valued at about $19,997,000. Alta Fox Capital Management LLC acquired a new stake in TriMas in the 1st quarter valued at about $17,385,000. Charles Schwab Investment Management Inc. lifted its stake in TriMas by 1.4% in the 1st quarter. Charles Schwab Investment Management Inc. now owns 614,023 shares of the industrial products company’s stock valued at $14,387,000 after purchasing an additional 8,521 shares during the last quarter. Finally, Hotchkis & Wiley Capital Management LLC grew its holdings in TriMas by 34.5% during the first quarter. Hotchkis & Wiley Capital Management LLC now owns 392,210 shares of the industrial products company’s stock worth $9,189,000 after purchasing an additional 100,610 shares during the period. 99.42% of the stock is owned by institutional investors.

Insider Activity

In other TriMas news, Director Jeffrey A. Fielkow purchased 2,000 shares of the firm’s stock in a transaction that occurred on Tuesday, November 11th. The shares were acquired at an average cost of $31.46 per share, for a total transaction of $62,920.00. Following the completion of the purchase, the director owned 17,653 shares of the company’s stock, valued at approximately $555,363.38. The trade was a 12.78% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 14.20% of the company’s stock.

TriMas Price Performance

TriMas stock opened at $33.74 on Tuesday. The company has a market capitalization of $1.37 billion, a price-to-earnings ratio of 31.24 and a beta of 0.64. The company has a current ratio of 2.68, a quick ratio of 1.44 and a debt-to-equity ratio of 0.56. TriMas Corporation has a 12 month low of $19.33 and a 12 month high of $40.34. The stock’s 50 day moving average is $35.49 and its 200-day moving average is $33.37.

TriMas (NASDAQ:TRSGet Free Report) last released its quarterly earnings results on Tuesday, October 28th. The industrial products company reported $0.61 earnings per share for the quarter, topping the consensus estimate of $0.57 by $0.04. The business had revenue of $269.26 million during the quarter, compared to analysts’ expectations of $262.05 million. TriMas had a return on equity of 12.39% and a net margin of 4.35%.The firm’s revenue for the quarter was up 17.4% compared to the same quarter last year. During the same period last year, the firm posted $0.43 EPS. TriMas has set its FY 2025 guidance at 2.020-2.120 EPS. Equities research analysts expect that TriMas Corporation will post 1.69 EPS for the current year.

TriMas Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, November 13th. Stockholders of record on Thursday, November 6th were issued a dividend of $0.04 per share. The ex-dividend date of this dividend was Thursday, November 6th. This represents a $0.16 dividend on an annualized basis and a dividend yield of 0.5%. TriMas’s dividend payout ratio (DPR) is currently 14.81%.

Analysts Set New Price Targets

TRS has been the topic of several research analyst reports. Weiss Ratings restated a “hold (c+)” rating on shares of TriMas in a research note on Monday, November 24th. BWS Financial reiterated a “buy” rating and set a $45.00 target price on shares of TriMas in a research note on Friday, October 31st. Zacks Research raised TriMas from a “hold” rating to a “strong-buy” rating in a report on Friday, August 29th. Finally, KeyCorp reduced their price objective on shares of TriMas from $45.00 to $38.00 and set an “overweight” rating for the company in a research report on Thursday, November 13th. One analyst has rated the stock with a Strong Buy rating, two have given a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Buy” and a consensus target price of $41.50.

Check Out Our Latest Report on TRS

About TriMas

(Free Report)

TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.

Featured Stories

Want to see what other hedge funds are holding TRS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for TriMas Corporation (NASDAQ:TRSFree Report).

Institutional Ownership by Quarter for TriMas (NASDAQ:TRS)

Receive News & Ratings for TriMas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TriMas and related companies with MarketBeat.com's FREE daily email newsletter.